DE60311013D1 - Synergistische leberschützende zusammensetzung und verfahren dazu - Google Patents

Synergistische leberschützende zusammensetzung und verfahren dazu

Info

Publication number
DE60311013D1
DE60311013D1 DE60311013T DE60311013T DE60311013D1 DE 60311013 D1 DE60311013 D1 DE 60311013D1 DE 60311013 T DE60311013 T DE 60311013T DE 60311013 T DE60311013 T DE 60311013T DE 60311013 D1 DE60311013 D1 DE 60311013D1
Authority
DE
Germany
Prior art keywords
synergistic
lively
tca
method therefor
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60311013T
Other languages
English (en)
Other versions
DE60311013T2 (de
Inventor
Vishwa Nath Gupta
Avtar Suri
Datt Gupta
Bupinder Singh Jaggi
Kumar Satti
Krishan Chandan
Neelam Sharma
Vikram Bhardwaj
Parkash Suri
Nabi Qazi
Jyotsna Suri
Madalsa Bargotra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60311013D1 publication Critical patent/DE60311013D1/de
Publication of DE60311013T2 publication Critical patent/DE60311013T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE60311013T 2003-03-31 2003-03-31 Synergistische leberschützende zusammensetzung und verfahren dazu Expired - Lifetime DE60311013T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000129 WO2004087127A1 (en) 2003-03-31 2003-03-31 Synergistic hepatoprotective composition and a method thereof

Publications (2)

Publication Number Publication Date
DE60311013D1 true DE60311013D1 (de) 2007-02-15
DE60311013T2 DE60311013T2 (de) 2007-10-11

Family

ID=33104978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60311013T Expired - Lifetime DE60311013T2 (de) 2003-03-31 2003-03-31 Synergistische leberschützende zusammensetzung und verfahren dazu

Country Status (6)

Country Link
EP (1) EP1608360B1 (de)
JP (1) JP2006514975A (de)
AT (1) ATE350031T1 (de)
AU (1) AU2003222445A1 (de)
DE (1) DE60311013T2 (de)
WO (1) WO2004087127A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104096045A (zh) * 2014-07-01 2014-10-15 胥玲 治疗痛风性关节炎的中药组合物
CN116003239B (zh) * 2022-11-27 2024-05-17 上海中医药大学 双环二萜类衍生物、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085710A1 (en) * 2000-05-05 2001-11-15 Dr. Reddy's Research Foundation Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them
US6629835B2 (en) * 2000-08-01 2003-10-07 Metaproteomics, Llc Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2

Also Published As

Publication number Publication date
WO2004087127A1 (en) 2004-10-14
DE60311013T2 (de) 2007-10-11
JP2006514975A (ja) 2006-05-18
ATE350031T1 (de) 2007-01-15
AU2003222445A1 (en) 2004-10-25
EP1608360A1 (de) 2005-12-28
EP1608360B1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
ATE232087T1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
BRPI0413394A8 (pt) Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio
ATE398998T1 (de) Micelläre arzneimittel zur bukkalen und pulmonaren anwendung
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MX250472B (es) Granulos o polvo para la produccion de agentes de recubrimiento y aglutinantes para formas farmaceuticas.
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
EA199800571A1 (ru) Антигрибковые композиции с улучшенной биологической доступностью
WO2003072713A3 (en) Use of bcma as an immunoregulatory agent
WO2004091521A3 (en) Methods and compositions for administration of trpv1 agonists
EE05533B1 (et) Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja ”strogeeni ning nende kasutamine
ATE434439T1 (de) Verfahren zu herstellung von zubereitungen enthaltend einen steroidhormon und ein stabilisierungsmittel in nicht-kristallinen form
HUT75513A (en) Taxane class derivative based pharmaceutical compositions and their preparation
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
EP1423414A4 (de) Neue depsipeptide und verfahren zu deren herstellung
CA2535013A1 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2004016243A3 (en) Methods of administering and enhancing absorption of pharmaceutical agents
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
NZ502840A (en) High pressure homogenisation method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
DE60311013D1 (de) Synergistische leberschützende zusammensetzung und verfahren dazu
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
MY135460A (en) Method of stimulating hair growth using benzopyrans
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition